| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 2 securities · may seek to influence control | ||||||
|
Heidrick & Struggles International Inc
13D
HSII · 422819102
|
5.8% |
11/5/2025
Event 10/27/2025
|
||||
| MAK Capital Fund LP | 5.8% | |||||
| MAK Capital One L.L.C. | 5.8% | |||||
| Michael A. Kaufman | 5.8% | |||||
|
Agilysys, Inc.
13D/A
AGYS · 00847J105
|
4.3% |
1/24/2025
Event 1/22/2025
|
||||
| Mak Capital Fund LP | 4.3% | |||||
| Mak Capital One L.L.C. | 4.3% | |||||
| Michael A. Kaufman | 4.3% | |||||
| Kaufman 2012 Descendants Trust | 0.8% | |||||
| Schedule 13G · 3 securities · passive | ||||||
|
Perma Fix Environmental Services Inc
13G/A
PESI · 714157203
|
4.8% |
8/28/2026
Event 8/24/2026
|
||||
| Mak Capital One LLC | 4.8% | |||||
| MAK Capital Fund LP | 4.8% | |||||
| Kaufman Michael A | 4.8% | |||||
|
Standard BioTools Inc.
13G/A
LAB · 34385P108
|
7.3% |
8/14/2026
Event 6/30/2026
|
||||
| Mak Capital One LLC | 7.3% | |||||
| MAK Capital Fund LP | 7.3% | |||||
| Kaufman Michael A | 7.3% | |||||
|
ClearPoint Neuro, Inc.
13G/A
CLPT · 18507C103
|
7.8% |
8/12/2026
Event 6/30/2026
|
||||
| Mak Capital One LLC | 7.8% | |||||
| MAK Capital Fund LP | 7.8% | |||||
| Kaufman Michael A | 7.8% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.